• OPEN AN ACCOUNT
Indian Indices
Sensex
72,711.48 329.01
( 0.45%)
Global Indices
Nasdaq
51,284.68 86.72
(0.17%)
Dow Jones
7,793.50 49.78
(0.64%)
Hang Seng
69,916.07 1,606.61
(2.35%)
Nikkei 225
10,489.44 27.49
(0.26%)
Forex
USD-INR
95.96 -0.21
(-0.22%)
EUR-INR
107.98 -0.51
(-0.47%)
GBP-INR
127.02 -0.14
(-0.11%)
JPY-INR
0.61 0.00
(-0.10%)

EQUITY - MARKET SCREENER

Shilpa Medicare Ltd
Industry :  Pharmaceuticals - Indian - Formulations
BSE Code
ISIN Demat
Book Value()
530549
INE790G01031
138.7336605
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
SHILPAMED
128.69
20160.57
EPS(TTM)
Face Value()
Div & Yield %
8.01
1
0.06
 

Rossari Biotech consolidated net profit rises 33.48% in the March 2026 quarter
Apr 28,2026
Net profit of Rossari Biotech rose 33.48% to Rs 45.97 crore in the quarter ended March 2026 as against Rs 34.44 crore during the previous quarter ended March 2025. Sales rose 18.17% to Rs 684.86 crore in the quarter ended March 2026 as against Rs 579.56 crore during the previous quarter ended March 2025.

For the full year,net profit rose 9.41% to Rs 149.21 crore in the year ended March 2026 as against Rs 136.38 crore during the previous year ended March 2025. Sales rose 15.19% to Rs 2396.37 crore in the year ended March 2026 as against Rs 2080.29 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales684.86579.56 18 2396.372080.29 15
OPM %11.2811.99 -11.9312.74 -
PBDT87.7765.93 33 281.64252.26 12
PBT64.2447.71 35 202.52185.19 9
NP45.9734.44 33 149.21136.38 9